Actively Recruiting
Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
Led by National Taiwan University Hospital · Updated on 2026-04-23
150
Participants Needed
1
Research Sites
191 weeks
Total Duration
On this page
Sponsors
N
National Taiwan University Hospital
Lead Sponsor
A
Alcon Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
Regular use of Systane COMPLETE in dry eye subjects before cataract surgery may optimize the ocular surface.
CONDITIONS
Official Title
Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 20 to 85 years
- Normal cognitive function and able to answer related questionnaires
- Require phacoemulsification and intraocular lens implantation under topical anesthesia
You will not qualify if you...
- Unable to answer questions in the dry eye survey
- History of ocular trauma or surgery in the planned surgical eye
- Active ocular infection
- Obvious abnormalities in ocular surface or eyelid margins besides MGD causing decreased vision other than cataracts
- Corneal Fluorescein Staining positive indicating corneal abnormalities or epithelial defects
- Using systemic drugs such as tetracycline derivatives, antihistamines, or isotretinoin
- Using dry eye medication at screening stage
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan, Taiwan
Actively Recruiting
Research Team
C
Chiun Ho Hou, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here